| Tag | Content |
|---|
EnhancerAtlas ID | HS018-05392 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr12:69166200-69168250 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOS | MA0476.1 | chr12:69167531-69167542 | TGTGACTCATT | + | 6.62 | | NR2C2 | MA0504.1 | chr12:69166869-69166884 | TGACCCTTGACCCCA | - | 6.61 | | Nr2f6 | MA0677.1 | chr12:69166869-69166883 | TGACCCTTGACCCC | - | 6.81 | | POU4F2 | MA0683.1 | chr12:69166314-69166330 | ATGAATTATTTATGAG | + | 6.14 | | Rxra | MA0512.2 | chr12:69166869-69166883 | TGACCCTTGACCCC | - | 7.1 | | ZBTB18 | MA0698.1 | chr12:69166893-69166906 | AAACATCTGGATT | - | 7.12 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_62175 | chr12:69164737-69203711 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr12 | 69166484 | 69166832 | | chr12 | 69166406 | 69167000 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I068772 | chr12 | 69166249 | 69168053 |
|
Enhancer Sequence | CATTTAATGT AATCATATTA CTTTCTTATA TTAGAAGATA GGATTTCTTC TGATGTATCG 60
AAGTTACTTT ATACTTCATA TGAAGTCATT AGGAGGTGAA TTATTGCCAA TTCAATGAAT 120
TATTTATGAG TATTAGGGGA ATGTTTTTGT TATGCTGCTT TTAATTTGGA AAGCAGCATA 180
TCACTCAAAC TATAGTAATT CACATTTTTC CATTTAACTA AAAATGTCTC GTAACTACTA 240
TGCCACAAGA ACAAGCATGG ATACTTATTT AACCAGCCAA GACTATGCAT TTCTAAATAT 300
TTATTTTTTT CGGTTATCCG TAGACTTTTC CTTTTGAAAT CCAACGATCT GTATCAACCA 360
CGTCTTCATT TTCCTTTTCC TGTTTGTCTT ACTCTCCCCC CAAAAAGAGT CAGTTTCCTG 420
TTTTCTCAAT TTCTCAGTTT AAAATTAGAG CCCTATGGCA GGTGCCATGT ACAGCTGCAA 480
AGGTGGCAAG AAGCCCTGAG AAAGCTCAAG AAGCAGGTCA AGGGGGTGGG TAAGGAAGAT 540
GGGACGTTCA AGCAGAAACA AAAAGAGGAG CTAAAAGTGA AAGCCACCCC GCCACCAGCC 600
CTCACCAGTC ACAGGTGGAA TTAAAGAAAT CTGGCAAAAA ATAAATTTTG TTATCCGTGC 660
TTGGGGCGGT GACCCTTGAC CCCATTCCTA TTTAAACATC TGGATTCTCT GCCATAACAT 720
CTTTTGCCAC CTATAGCTAC AATAAAGTGT CGTCTTGGAG TCTGTTGTAC ATTTAAGAAT 780
AAACTTTTGT AAGGAAGTAA AAAAGAGTCT ACAGTTCAGT GCAGGATAGG GATGGGTGGG 840
CCTTAATTCA GGAGGTGGGA GGCTCAAAAT CAATTACTCT GTTGAGGAGA TGGAATCTCC 900
TGGAATCTCA AAAAGGATTT CCTTTAGGAA TCATCAGACT CATCCGACTC GTCAAGTCTT 960
TCTCTGCTTG GAGTTTTGTT TTGTTTTTAT TTTGTTTTGT TTTGGAGATA GGTTCTCCCT 1020
CTGTCACCCA GGCTGGAGTG CAGTGGTGCA ATCACAGCTC ACTGCAGCCT CGAATTCCTA 1080
GGCTCAAGTG ATCCTCCCAC CTCAGCCTCC TGAGTAGCTG GGACTACAGG TGTGCACCAA 1140
CAGGCCCAGA TAATTTTATT TTTTGTAGAG ACGGGGTCTT GCTATGTTGC CAGGCTGGTC 1200
TCCAACTCCT GGCCTCAAGT GATCCTCTTG CTCTGCCTCC CGAAGTGCTA AAATTACAGC 1260
TGTGAAACAC CGCGCCTGGA GTTTAAAAGC AAGATTAACC TTTTTGGACT GGAGTTCTTA 1320
GAGAATTATG GTGTGACTCA TTGACCATAT TTGTTAGGAT CAGCATTTTT ATATGATTTA 1380
ACACAAAATG TTACAGAAAA AAGTGCAAAA ATGTTGTAAG GCACAGTTGG TTTCCTAAGC 1440
AAATGCCCAT TCCTATTCTT TGTTCATCTC CACTCTAGAG GCTAGAAATA CTAAATTCTC 1500
TTTTTACCTC GTTGCCTTGT AGAGGGATGA TCATATGACA TTTCACCAAT GGCACATAAT 1560
TCAAAGTCTG CTGAGGATTT CTAGGGTATC CTGATTAAAA GGGACAGATG TGGCTGGTAG 1620
TGTCTATTAC CACCTCCTTC CTGCCTTAAA TGTAGCTGCG GATGTCTAGA ATTGTGCTAA 1680
TCAGCTTATG ACTATAAAAG AGAGGTGAAG AGAGCCAGAT CTGAAAGTGG TGAGCCGACC 1740
AGGCACAGTG GCACACCTGT AACCCCAGCA CTTTGGGAGG CCGAGGGAGG AGGATCATTT 1800
GAGCCCAGGA GTTTGAGACC AGCCTGGGCA ACATTGCAAA ACCTGTTCTC TGTGAATAAC 1860
TTAAAAATTA GTCAGGTGGC CAGGCGTAGT GGTTCACACC TGCAATCTCA GCACTTTGGA 1920
AGGCTGAGGT GGGTGGATCA CCTGAGGTCA GGAGTTCGAG ACCAGCCTGA CCAACATGGA 1980
GAAACCCTGT CTCTACTAAA AATACAAAAT TAGCTGGGCG TAGTGGCTTA TGCCTGTAAC 2040
CCCAGCTACT 2050
|
